Gilead Sciences Inc (GILD)
Debt-to-assets ratio
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | 23,189,000 | 23,189,000 | 21,209,000 | 22,956,000 | 22,957,000 | 22,953,000 | 25,195,000 | 25,183,000 | 25,179,000 | 25,175,000 | 27,914,000 | 27,907,000 | 28,645,000 | 27,792,000 | 21,103,000 | 22,098,000 | 22,094,000 | 22,090,000 | 24,084,000 | 24,080,000 |
Total assets | US$ in thousands | 62,125,000 | 62,373,000 | 62,337,000 | 61,876,000 | 63,171,000 | 62,557,000 | 62,870,000 | 63,080,000 | 67,952,000 | 67,098,000 | 67,984,000 | 67,492,000 | 68,407,000 | 60,878,000 | 55,934,000 | 59,741,000 | 61,627,000 | 59,146,000 | 63,210,000 | 62,837,000 |
Debt-to-assets ratio | 0.37 | 0.37 | 0.34 | 0.37 | 0.36 | 0.37 | 0.40 | 0.40 | 0.37 | 0.38 | 0.41 | 0.41 | 0.42 | 0.46 | 0.38 | 0.37 | 0.36 | 0.37 | 0.38 | 0.38 |
December 31, 2023 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $23,189,000K ÷ $62,125,000K
= 0.37
The debt-to-assets ratio of Gilead Sciences, Inc. has been relatively stable around the range of 0.40 to 0.42 over the past eight quarters. This indicates that, on average, the company has been financing approximately 40% to 42% of its assets with debt during this period.
A debt-to-assets ratio of less than 1 suggests that Gilead Sciences has more assets than debt, which can be considered a positive sign as it indicates lower financial risk. However, the slight increase in the ratio from 0.40 in Q4 2022 to 0.42 in Q2 2022 and Q1 2022 could imply that the company has taken on slightly more debt relative to its assets in those quarters.
Overall, the consistent range of the debt-to-assets ratio around 0.40 to 0.42 indicates that Gilead Sciences has been maintaining a prudent balance between debt and assets in its capital structure, which is important for financial stability and long-term sustainability. Further analysis of the company's financial health and performance alongside other key financial ratios would provide a more comprehensive assessment.
Peer comparison
Dec 31, 2023